E-ISSN 2756-4053 | ISSN 2705-3156
 

Research Article 


ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT

Jude Nwaogu, Yakubu Musa Yanah.


Abstract
Diabetes mellitus is characterized by chronic hyperglycaemia with disturbances of carbohydrates, fat, and protein metabolism resulting from the defect of insulin secretion or insulin action. Parkia biglobosais is traditionally used in Nigeria to treat a range of ailments and diseases including diarrhoea, pneumonia, ulcers, burns, coughs, jaundice and diabetes. In this present study, the anti-hyperglycemic effect of methanol leaf extract of Parkia biglobosa was investigated against Alloxan induced diabetes in rats. A total of twenty five (25) rats were randomly allocated to 5 groups of 5 rats each. Group 1 served as the normal control, group 2 served as diabetic control, Group 3 receive a standard drug and serve as control (glibenclimide 2.5mg/kg b.w) while Groups 4-5 were treated with methanol leaf extract of Parkia biglobosa (100mg and 300mg) respectively. All treatments were administered orally for 28 days. Fasting blood glucose level and body weight were monitored during the study period. Results obtained reveal that there was no significant decrease (p<0.05) in the body weight and in the blood glucose level of diabetic untreated rats. However, treatment with the extract of P. biglobosa leaf significantly decreased (p<0.05) blood glucose level when compared with the untreated control. The 300mg/kg dose of methanol extract had the best activity with significant reduction (p<0.05) in the blood glucose level when compared to the normal control. Based on the results obtained. It can therefore be concluded that methanol leaf extract of Parkia biglobosa possess significant anti-hyperglycaemic properties against Alloxan induced diabetes in rats with the 300mg/kg dose of the methanol leaf extract being the most potent dose of the extract, thus it can serve as a potent remedy for hyperglycaemia.

Key words: anti-diabetic, alloxan, leaf, glibenclimide, Parkia biglobosa.


 
ARTICLE TOOLS
Abstract
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Jude Nwaogu
Articles by Yakubu Musa Yanah
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Nwaogu J, Yanah YM. ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. JIRLS. 0; 0(0): 0-0.


Web Style

Nwaogu J, Yanah YM. ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. https://www.jirlsonline.com/?mno=171329 [Access: November 17, 2025].


AMA (American Medical Association) Style

Nwaogu J, Yanah YM. ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. JIRLS. 0; 0(0): 0-0.



Vancouver/ICMJE Style

Nwaogu J, Yanah YM. ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. JIRLS. (0), [cited November 17, 2025]; 0(0): 0-0.



Harvard Style

Nwaogu, J. & Yanah, . Y. M. (0) ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. JIRLS, 0 (0), 0-0.



Turabian Style

Nwaogu, Jude, and Yakubu Musa Yanah. 0. ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. Journal of Innovative Research in Life Sciences, 0 (0), 0-0.



Chicago Style

Nwaogu, Jude, and Yakubu Musa Yanah. "ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT." Journal of Innovative Research in Life Sciences 0 (0), 0-0.



MLA (The Modern Language Association) Style

Nwaogu, Jude, and Yakubu Musa Yanah. "ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT." Journal of Innovative Research in Life Sciences 0.0 (0), 0-0. Print.



APA (American Psychological Association) Style

Nwaogu, J. & Yanah, . Y. M. (0) ANTI-DIABETIC EFFECT OF METHANOL LEAF EXTRACT OF PARKIA BIGLOBOSA IN ALLOXAN-INDUCED DIABETIC RAT. Journal of Innovative Research in Life Sciences, 0 (0), 0-0.